Stereotaxis Inc RJR1
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €1.96
- Day Range
- €1.96–1.96
- 52-Week Range
- —–8.45
- Bid/Ask
- €1.89 / €1.97
- Market Cap
- €161.98 Mil
- Volume/Avg
- 0 / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 6.47
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service and accessories stream. The company generates the majority of revenue from the United States.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Value
- Total Number of Employees
- 122
- Website
- https://www.stereotaxis.com
Comparables
Valuation
|
Metric
|
RJR1
|
IRMD
|
PRCT
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 27.09 | — |
Price/Book Value | 11.93 | 6.99 | 13.25 |
Price/Sales | 6.47 | 7.91 | 21.23 |
Price/Cash Flow | — | 25.72 | — |
Price/Earnings
RJR1
IRMD
PRCT
Financial Strength
|
Metric
|
RJR1
|
IRMD
|
PRCT
|
|---|---|---|---|
Quick Ratio | 1.68 | 7.64 | 7.29 |
Current Ratio | 2.43 | 9.44 | 8.52 |
Interest Coverage | — | — | −26.17 |
Quick Ratio
RJR1
IRMD
PRCT
Profitability
|
Metric
|
RJR1
|
IRMD
|
PRCT
|
|---|---|---|---|
Return on Assets (Normalized) | −20.71% | 23.22% | −22.89% |
Return on Equity (Normalized) | −49.18% | 27.73% | −34.45% |
Return on Invested Capital (Normalized) | −34.50% | 26.92% | −27.37% |
Return on Assets
RJR1
IRMD
PRCT
Medical Instruments & Supplies Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ISRG
| Intuitive Surgical Inc | Dqtzdkmqs | Fpxy | $140.6 Bil | |
BDX
| Becton Dickinson & Co | Ktjmkkvs | Xhjmddh | $68.3 Bil | |
ALC
| Alcon Inc | Rskqnqck | Fjxsbpp | $43.6 Bil | |
RMD
| ResMed Inc | Bswrgscx | Wqrtlm | $32.1 Bil | |
CLPBY
| Coloplast A/S ADR | Fclvcdgdj | Nhr | $27.9 Bil | |
WST
| West Pharmaceutical Services Inc | Qtzmyzpm | Tfbr | $26.0 Bil | |
COO
| The Cooper Companies Inc | Lhtfrbmz | Xvyxxs | $19.3 Bil | |
BAX
| Baxter International Inc | Ghjwypmj | Cchcvx | $18.1 Bil | |
HOLX
| Hologic Inc | Kjbybjyvz | Yzlqg | $17.5 Bil | |
TFX
| Teleflex Inc | Gxzt | Rqgmb | $10.3 Bil |